To study the involvement of acyl carrier protein (ACP) in the metabolism of exogenous fatty acids in Vibrio harveyi, cultures were incubated in minimal medium with [9,10-3H]myristic acid, and labeled proteins were analyzed by gel electrophoresis. Labeled acyl-ACP was positively identified by immunoprecipitation with anti-V. harveyi ACP serum and comigration with acyl-ACP standards and [3H] 0-alanine-labeled bands on both sodium dodecyl sulfate-and urea-polyacrylamide gels. Surprisingly, most of the acyl-ACP label corresponded to fatty acid chain lengths of less than 14 carbons: C14, C12, CIO and C8 represented 33, 40, 14, and 8% of total [3HI 14:0-derived acyl-ACPs, respectively, in a dark mutant (M17) of V. harveyi which lacks myristoyl-ACP esterase activity; however, labeled 14:0-ACP was absent in the wild-type strain. 14:0-and 12:0-ACP were also the predominant species labeled in complex medium. In contrast, short-chain acyl-ACPs (sC6) were The mechanism of uptake and degradation of exogenous fatty acids in Escherichia coli is well established; for reviews, see references 19, 24, and 35. The uptake of long-chain fatty acids involves protein-mediated transport across the outer membrane (2) and then activation to acyl coenzyme A (acylCoA) by acyl-CoA synthetase on the cytoplasmic side of the inner membrane (20). These fatty acids can then be incorporated into membrane phospholipids by glycerol 3-phosphate acylation (14) or degraded to acetyl coenzyme A (acetyl-CoA) via a-oxidation (24). In contrast, de novo fatty acid synthesis involves elongation of acyl-acyl carrier protein (acyl-ACP) intermediates; these ultimately serve as donors for the acylation of both phospholipids and the lipid A moiety of outer membrane lipopolysaccharides (27) . Exogenous fatty acids are not elongated in E. coli, indicating that they do not have access to biosynthetic pathways involving acyl carrier protein (ACP) (33). Although exogenous fatty acids can be transferred to phospholipids by 2-acylglycerophosphatidylethanolamine acyltransferase/acyl-ACP synthetase (10, 17), the transient acyl-ACP intermediates bound to this inner membrane enzyme are not available to enzymes of fatty acid biosynthesis or glycerol 3-phosphate acylation. Thus, there is no acyl group exchange between acyl-CoA and acyl-ACP, and the biosynthesis and degradation of fatty acids are chemically segregated in E. coli. We previously showed that the metabolism of exogenous fatty acids in the bioluminescent bacterium Vibrio harveyi exhibits a number of differences from that in E. coli, despite overall similarities in the fatty acid and phospholipid compositions of these gram-negative organisms (5). First, exogenous labeled fatty acids can be elongated prior to incorporation into phospholipids in V harveyi (6), indicating that these fatty acids have access to biosynthetic pathways. Second, there is a small transient pool of unesterified fatty acids (5), arising from the action of a luminescence-specific esterase which specifically cleaves 14:0-ACP to supply 14:0 for reduction to form the myristyl aldehyde substrate of luciferase (8, 11); free 14:0 is regenerated by light-emitting luciferase oxidation. Myristoyl-ACP esterase is defective in a dark mutant strain of V harveyi (mutant M17) which requires exogenous 14:0 for light emission (23, 34). Finally, we recently isolated from V harveyi a soluble acyl-ACP synthetase which is capable of activating a broad range of fatty acids to acyl-ACP in vitro (7, 12, 32) .
[3H]14:0 in vivo is not due to the total degradation of [3HI 14:0 to [3H]acetyl coenzyme A followed by resynthesis. Cerulenin increased the mass of medium-to long-chain acyl-ACPs (.C8) labeled with [3HI jalanine fivefold, while total incorporation of [3H] 14:0 was not afected, although a shift to shorter chain lengths was noted. Additional bands which comigrated with acyl-ACP on sodium dodecyl sulfate gels were identified as lipopolysaccharide by acid hydrolysis and thin-layer chromatography. The levels of incorporation of [3H] 14:0 into acyl-ACP and lipopolysaccharide were 2 and 15%, respectively, of that into phospholipid by 10 min. Our results indicate that, in contrast to the situation in Escherichia coli, exogenous fatty acids can be activated to acyl-ACP intermediates after partial degradation in V. harveyi and can effectively label products (i.e., lipid A) that require ACP as an acyl donor.
The mechanism of uptake and degradation of exogenous fatty acids in Escherichia coli is well established; for reviews, see references 19, 24, and 35 . The uptake of long-chain fatty acids involves protein-mediated transport across the outer membrane (2) and then activation to acyl coenzyme A (acylCoA) by acyl-CoA synthetase on the cytoplasmic side of the inner membrane (20) . These fatty acids can then be incorporated into membrane phospholipids by glycerol 3-phosphate acylation (14) or degraded to acetyl coenzyme A (acetyl-CoA) via a-oxidation (24) . In contrast, de novo fatty acid synthesis involves elongation of acyl-acyl carrier protein (acyl-ACP) intermediates; these ultimately serve as donors for the acylation of both phospholipids and the lipid A moiety of outer membrane lipopolysaccharides (27) . Exogenous fatty acids are not elongated in E. coli, indicating that they do not have access to biosynthetic pathways involving acyl carrier protein (ACP) (33) . Although exogenous fatty acids can be transferred to phospholipids by 2-acylglycerophosphatidylethanolamine acyltransferase/acyl-ACP synthetase (10, 17) , the transient acyl-ACP intermediates bound to this inner membrane enzyme are not available to enzymes of fatty acid biosynthesis or glycerol 3-phosphate acylation. Thus, there is no acyl group exchange between acyl-CoA and acyl-ACP, and the biosynthesis and degradation of fatty acids are chemically segregated in E. coli.
We previously showed that the metabolism of exogenous fatty acids in the bioluminescent bacterium Vibrio harveyi exhibits a number of differences from that in E. coli, despite overall similarities in the fatty acid and phospholipid compositions of these gram-negative organisms (5) . First, exogenous labeled fatty acids can be elongated prior to incorporation into phospholipids in V harveyi (6) , indicating that these fatty acids have access to biosynthetic pathways. Second, there is a small transient pool of unesterified fatty acids (5), arising from the action of a luminescence-specific esterase which specifically cleaves 14:0-ACP to supply 14:0 for reduction to form the myristyl aldehyde substrate of luciferase (8, 11) ; free 14:0 is regenerated by light-emitting luciferase oxidation. Myristoyl-ACP esterase is defective in a dark mutant strain of V harveyi (mutant M17) which requires exogenous 14:0 for light emission (23, 34) . Finally, we recently isolated from V harveyi a soluble acyl-ACP synthetase which is capable of activating a broad range of fatty acids to acyl-ACP in vitro (7, 12, 32) .
Elongation of exogenous fatty acids in V harveyi could in principle occur by a number of possible mechanisms, including: (i) activation and elongation as acyl-CoA derivatives, as occurs in eucaryotes (9) V. harveyi ACP and acyl-ACP standards. V harveyi ACP was purified by a modification of the procedure described by Rock and Cronan (28) for E. coli ACP (31a). V harveyi acyl-ACP standards with acyl chain lengths of C6 to C16 were prepared by use of 14C-labeled fatty acids and partially purified V harveyi acyl-ACP synthetase as previously described (32) . A rabbit anti-ACP serum was prepared against purified V harveyi ACP by subcutaneous injection of 250 ,ug of ACP in 1 ml of Freund's complete adjuvant (15 Laemmli (21) with resolving and stacking gels of 15 and 4% (wt/vol) acrylamide, respectively. Polyacrylamide gels containing 2 M urea were prepared as described by Post-Beittenmiller et al. (26) with 15 and 5% (wt/vol) acrylamide resolving and stacking gels, respectively. No urea was added to the running buffer (3.1 g of Tris-bis and 14.4 g of glycine per liter). Lysate samples or acyl-ACP standards were diluted with equal volumes of 2 xconcentrated SDS sample buffer before being loaded onto either SDS-or urea-polyacrylamide gels. After electrophoresis, protein bands in SDS gels were visualized by staining with Coomassie blue, and the labeled proteins were visualized by fluorography with Kodak X-Omat AR film without flashing as described previously (37) . Urea gels were soaked in at least two changes of fixing solution (10% acetic acid-30% methanol [vol/vol] . acyl-ACP intermediates) with [3H]14:0 resulted in the labeling of proteins which were immunoprecipitated with anti-V. harveyi ACP serum but not preimmune serum. These bands comigrated with authentic '4C-acyl-ACP standards (C8 to C14), which were well resolved in this gel system, with migration increasing as a function of fatty acid chain length (Fig. 1 ).
Incubation with [3H]P-alanine (a specific precursor of the pantotheine prosthetic group of ACP) also resulted in the labeling of medium-to long-chain acyl-ACPs, as well as higher-molecular-weight bands corresponding to free ACP and short-chain (<C8) harveyi cells (Fig. 1, WT (Fig. 2) . 12 :0-ACP was the major acyl-ACP band, representing 46% of the total label associated with acyl-ACPs, and short-chain acyl-ACPs (sC6) were not detected; however, short-chain acyl-ACPs represented 52% of the total acyl-ACP label from [3H]acetate, and 12:0-ACP represented <10% (Fig. 2) Effect of cerulenin on acyl-ACP intermediates. To determine whether acyl-ACP intermediates derived from (partially degraded) exogenous labeled fatty acids can undergo chain elongation, V harveyi M17 cells were incubated with labeled precursors in the presence or absence of cerulenin, which blocks fatty acid synthesis by irreversibly inhibiting 3-ketoacyl-ACP synthase (25) . Cerulenin had a dramatic effect on the relative mass composition of acyl-ACPs labeled with [3H]13-alanine, with large increases in the amounts of 8:0-ACP (25-fold) and 10:0-ACP (16-fold) (Fig. 3A) Fig. 4 , immunoprecipitated acyl-ACPs labeled in vivo with either [3H],-alanine or [3H]14:0 could also be resolved by SDS-PAGE (note that the migration of long-chain acyl-ACPs decreases as a function of chain length in this gel system). However, in contrast to the situation with urea gels in which acyl-ACP composition could be directly analyzed without immunoprecipitation, we observed that most of the [3H]14:0-labeled material which migrated in the acyl-ACP region of SDS gels was not immunoprecipitated with anti-ACP serum (Fig. 4) .
We investigated the possibility that these labeled bands might correspond to lipopolysaccharide, which is known to migrate as defined bands or "ladders" in SDS gels (38) . In the experiment shown in Fig (4) .
DISCUSSION
The present study has clearly shown that acyl chains derived from exogenous myristic acid can be activated to form acyl-ACP and lipid A in V. harveyi. Acyl-ACPs labeled by incubation with [9,10-3H]14:0 were positively identified by (i) comigration with authentic acyl-ACP standards in two different gel systems, (ii) comigration with acyl-ACP labeled specifically with [3H],B-alanine, and (iii) immunoprecipitation with anti-V harveyi ACP serum. To our knowledge, this is the first direct demonstration of the activation of exogenous fatty acids to biosynthetic acyl-ACP intermediates in bacteria and provides strong evidence that the elongation of these fatty acids observed previously for V harveyi involves ACP (5, 6 ). The present results also provide a further contrast to fatty acid metabolism in E. coli, in which exogenous fatty acids can be activated to both acyl-CoA and acyl-ACP at the inner cell membrane (30) , but neither intermediate has access to pathways of fatty acid synthesis. In E. coli, acyl-CoA is oxidized or incorporated directly into phospholipids by glycerol-3-phosphate acyltransferase (14) , while acyl-ACP derived from exogenous fatty acids is a transient, tightly bound intermediate in the reacylation of the 1 position of phosphatidylethanolamine and is not elongated (10, 17) . V. harveyi also differs from E. coli in that fatty acids do not appear to induce enzymes responsible for their metabolism (i.e., a fad-like operon), nor can they support growth in the absence of other carbon sources (6) .
An unexpected result of this study, and one that would not be predicted from earlier metabolic labeling studies, is that exogenous 14:0 can be partially degraded to shorter chain lengths prior to acyl-ACP formation. An (Fig. 2) : fatty acid label appeared exclusively in medium-to long-chain (C8 to C14) acyl-ACPs, while acetate label appeared mostly in shorter-chain derivatives (.C6). These differences occurred without a substantial influence of either 14:0 or acetate on acyl-ACP pool sizes (Fig. 3B) . Moreover, only one-sixth of the label in [9,10- A model of exogenous fatty acid metabolism in V. harveyi that is consistent with the findings of this and earlier studies is presented in Fig. 6 . On the basis of the appearance of labeled acyl-ACPs with chain lengths shorter than 14:0, as well as the observed formation of 14C02 from [1-14C] 14:0 (6), we suggest that exogenous 14:0 may be initially activated to acyl-CoA (as in E. coli) and partially oxidized as CoA derivatives. These partially degraded acyl moieties can be transferred from acyl-CoA to ACP and can also be reelongated by fatty acid synthase. The latter step would be blocked by cerulenin, resulting in the observed shift of labeled acyl-ACPs to shorter chain lengths (Fig. 3) . The dramatic decrease in the amount of labeled 14:0-ACP in the presence of cerulenin likely reflects its efficient use as an intermediate in phospholipid acylation (14:0 is about 10% of total V harveyi fatty acids [5] ) in the absence of competing endogenous 14:0-ACP. Note that our results do not rule out direct activation or transfer of at least some of the intact 14:0 chain to ACP (i.e., without degradation). Indeed, (7, 12, 32) and could in theory be involved in the activation of free fatty acids to acyl-ACP in vivo.
The relative levels of acyl-ACP intermediates should reflect the balance of enzyme activities involved in their synthesis and utilization. In bioluminescent bacteria, 14:0-ACP is the specific substrate of a luminescence-related esterase which provides endogenous 14:0 for aldehyde synthesis (8, 11) . This study indicates that the presence of this enzyme in wild-type V harveyi dramatically affects the species of acyl-ACP labeled with exogenous [3H]14:0, as labeled 14:0-ACP was virtually absent in wild-type cells compared with M17 cells incubated in minimal medium (Fig. 1) . The amount of labeled 14:0-ACP was also decreased in the presence of cerulenin, while 8:0-ACP and 10:0-ACP accumulated (Fig. 3) . These results suggest that elongation of longer-chain acyl-ACPs might be particularly sensitive to cerulenin and that 14:0-ACP (a suitable substrate for phospholipid acylation) is quickly removed under these conditions. The composition of the growth medium also affected the labeling of acyl-ACP with [3H]14:0 in minimal medium; the balance appeared to be shifted towards oxidation of 14:0 prior to ACP acylation, with acyl-ACPs as short as C8 being detected, while less degradation of 14:0 was noted in complex medium, in which 12:0-ACP was the only shortened product observed. The Previous investigations examining the mass composition of acyl-ACP pools in both plants (26, 31) and E. coli (18, 29) have been valuable in providing insight into the rate-determining steps in fatty acid biosynthesis. The incorporation of exogenous fatty acid precursors in V harveyi should provide another dimension to this approach, particularly in studies of the control of the synthesis of less abundant cell components that require acyl-ACP as acyl donors, such as secreted proteins (16) and lipid A. In E. coli, the transfer of fatty acids from 3-hydroxymyristoyl-ACP to UDP-GlcNAc is the first committed step in the synthesis of lipid A (1, 27) . While lipid A cannot be directly labeled with exogenous fatty acids in E. coli (4), it is effectively labeled with [ H]14:0 in V harveyi (Fig. 5 ). As 12:0-ACP and 14:0-ACP are the major labeled acyl-ACP intermediates, we would expect that all the major fatty acids of lipid A (12:0, 1-hydroxy-14:0, and 14:0) would also be labeled to some extent; further characterization of V harveyi lipid A is presently under way. In any case, V harveyi should provide a Exogenous fatty acid good model for studying competition for acyl-ACP intermediates between different pathways and products, shedding light on, for example, the regulatory process which diverts about 20% of acyl-ACP to the formation of lipid A rather than phospholipid (19) .
